Case report
Rhabdomyolysis Associated With Pomegranate Juice Consumption

https://doi.org/10.1016/j.amjcard.2006.03.057Get rights and content

This 48-year-old man with possible underlying myopathy was successfully treated with ezetimibe 10 mg/day and rosuvastatin 5 mg every other day for 17 months. Three weeks before presentation, he began drinking pomegranate juice (200 ml twice weekly). He presented urgently with thigh pain and an elevated serum creatine kinase level (138,030 U/L, normal <200 U/L). In conclusion, because both grapefruit and pomegranate juice are known to inhibit intestinal cytochrome P450 3A4, this report suggests that pomegranate juice may increase the risk of rhabdomyolysis during rosuvastatin treatment, despite the fact that rosuvastatin is not known to be metabolized by hepatic P450 3A4.

References (7)

  • A.M. Karch

    The grapefruit challengethe juice inhibits a crucial enzyme, with possibly fatal consequences

    Am J Nurs

    (2004)
  • M. Hidaka et al.

    Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats

    Drug Metab Dispos

    (2005)
  • The new juice in town

    Consumer Reports

    (2005)
There are more references available in the full text version of this article.

Cited by (0)

View full text